论文信息 - Continuous subarachnoid analgesia using implantable drug delivery system for cancer pain - 字舞流文

Continuous subarachnoid analgesia using implantable drug delivery system for cancer pain

M. Takada | M. Mineta | H. Ogawa | Mitsuaki Matoba | Y. Takeda | Y. Iwanami

[1] G. Rolly,et al. Spinal analgesia in terminal care: risk versus benefit. , 1994, Journal of pain and symptom management.

[2] I. Curelaru,et al. Bacteriology, Drug Stability and Exchange of Percutaneous Delivery Systems and Antibacterial Filters in Long‐Term Intrathecal Infusion of Opioid Drugs and Bupivacaine in “Refractory” Pain , 1992, The Clinical journal of pain.

[3] S. Einarsson,et al. Long‐term intrathecal morphine and bupivacaine in “refractory” cancer pain. I. Results from the first series of 52 patients , 1991, Acta anaesthesiologica Scandinavica.

[4] R. Dickson,et al. Pain unresponsive to high dose opiate drugs , 1989 .

[5] S. Dupen,et al. COMPOUNDING LOCAL ANESTHETICS AND NARCOTICS FOR EPIDURAL ANALGESIA IN CANCER OUT-PATIENTS , 1988 .

[6] S. Arnér,et al. Differential Effects of Epidural Morphine in the Treatment of Cancer‐related Pain , 1985, Acta anaesthesiologica Scandinavica.